TG Therapeutics Inc. (TGTX)

7.04
0.21 3.07
NASDAQ : Health Technology
Prev Close 6.83
Open 6.86
Day Low/High 6.81 / 7.11
52 Wk Low/High 3.32 / 17.35
Volume 1.51M
Avg Volume 2.04M
Exchange NASDAQ
Shares Outstanding 87.97M
Market Cap 600.84M
EPS -2.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Noteworthy Friday Option Activity: TGTX, SHAK, NPTN

Noteworthy Friday Option Activity: TGTX, SHAK, NPTN

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in TG Therapeutics Inc , where a total of 14,760 contracts have traded so far, representing approximately 1.5 million underlying shares. That amounts to about 74.9% of TGTX's average daily trading volume over the past month of 2.0 million shares.

3 Recent Big Gainers Kick Off the Dramatic Return of 'Small-Cap Friday'

3 Recent Big Gainers Kick Off the Dramatic Return of 'Small-Cap Friday'

Small-caps have done better than their bigger brethren so far in 2019, and these three stocks are a reason why.

MONDAY DEADLINE REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against TG Therapeutics, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

MONDAY DEADLINE REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against TG Therapeutics, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of TG Therapeutics, Inc.

MONDAY DEADLINE: The Schall Law Firm Announces It Is Investigating Claims Against TG Therapeutics, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

MONDAY DEADLINE: The Schall Law Firm Announces It Is Investigating Claims Against TG Therapeutics, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of TG Therapeutics, Inc.

Scott Scott Attorneys At Law LLP Reminds Investors Of Securities Class Action Against TG Therapeutics, Inc. (TGTX) And December 3 Lead Plaintiff Deadline

Scott Scott Attorneys At Law LLP Reminds Investors Of Securities Class Action Against TG Therapeutics, Inc. (TGTX) And December 3 Lead Plaintiff Deadline

Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, reminds investors that a class action lawsuit has been filed against TG Therapeutics, Inc.

Glancy Prongay & Murray LLP Reminds Investors Of The Deadline In The Class Action Lawsuit Against TG Therapeutics, Inc. Investors (TGTX)

Glancy Prongay & Murray LLP Reminds Investors Of The Deadline In The Class Action Lawsuit Against TG Therapeutics, Inc. Investors (TGTX)

Glancy Prongay & Murray LLP ("GPM") reminds investors of the December 3, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased TG Therapeutics, Inc.

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In TG Therapeutics, Inc. To Contact The Firm

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In TG Therapeutics, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in TG Therapeutics, Inc.

Federman & Sherwood Reminds Investors Of Imminent Lead Plaintiff Deadline In Securities Class Action Lawsuit Against TG Therapeutics, Inc.

Federman & Sherwood Reminds Investors Of Imminent Lead Plaintiff Deadline In Securities Class Action Lawsuit Against TG Therapeutics, Inc.

On October 4, 2018, a class action lawsuit was filed in the United States District Court for the Southern District of New York against TG Therapeutics, Inc.

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In TG Therapeutics, Inc. To Contact The Firm

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In TG Therapeutics, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in TG Therapeutics, Inc.

Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of TG Therapeutics, Inc. Investors

Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of TG Therapeutics, Inc. Investors

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors that purchased TG Therapeutics, Inc.

Scott Scott Attorneys At Law LLP Reminds Investors Of Securities Class Action Against TG Therapeutics, Inc. (TGTX) And December 3 Lead Plaintiff Deadline

Scott Scott Attorneys At Law LLP Reminds Investors Of Securities Class Action Against TG Therapeutics, Inc. (TGTX) And December 3 Lead Plaintiff Deadline

Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, reminds investors that a class action lawsuit has been filed against TG Therapeutics, Inc.

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In TG Therapeutics, Inc. To Contact The Firm

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In TG Therapeutics, Inc. To Contact The Firm

NEW YORK, Nov. 2, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in TG Therapeutics, Inc.

Lifshitz & Miller LLP Announces Investigation Of Adient PLC, Applied Optoelectronics, Inc., Cocrystal Pharma, Inc., Microchip Technology Incorporated, MGT Capital Investments, Inc., TG Therapeutics, Inc. And USA Technologies, Inc.

Lifshitz & Miller LLP Announces Investigation Of Adient PLC, Applied Optoelectronics, Inc., Cocrystal Pharma, Inc., Microchip Technology Incorporated, MGT Capital Investments, Inc., TG Therapeutics, Inc. And USA Technologies, Inc.

NEW YORK, Oct. 30, 2018 /PRNewswire/ --  Adient PLC (ADNT) Lifshitz & Miller announces investigation into possible securities laws violations in connection with ADNT's CEO stepping down and decreased profit forecast for the year.

TGTX LOSS NOTICE: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against TG Therapeutics, Inc.; Important Deadline - TGTX

TGTX LOSS NOTICE: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against TG Therapeutics, Inc.; Important Deadline - TGTX

NEW YORK, Oct. 26, 2018 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of TG Therapeutics, Inc.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of TG Therapeutics, Inc. - TGTX

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of TG Therapeutics, Inc. - TGTX

NEW YORK, Oct. 17, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of TG Therapeutics, Inc.

Glancy Prongay & Murray LLP Announces Investigation On Behalf Of TG Therapeutics, Inc. Investors (TGTX)

Glancy Prongay & Murray LLP Announces Investigation On Behalf Of TG Therapeutics, Inc. Investors (TGTX)

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of TG Therapeutics, Inc.

TG THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In TG Therapeutics, Inc. To Contact The Firm

TG THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In TG Therapeutics, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against TG Therapeutics, Inc.

TGTX LOSS NOTICE: Rosen Law Firm Reminds TG Therapeutics, Inc. Investors Of Important Deadline In Class Action - TGTX

TGTX LOSS NOTICE: Rosen Law Firm Reminds TG Therapeutics, Inc. Investors Of Important Deadline In Class Action - TGTX

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of TG Therapeutics, Inc.

Johnson Fistel Files Class Action Suit Against TG Therapeutics, Inc.

Johnson Fistel Files Class Action Suit Against TG Therapeutics, Inc.

SAN DIEGO, Oct. 12, 2018 /PRNewswire/ -- Johnson Fistel, LLP announces that a class action has been commenced on behalf of purchasers of TG Therapeutics, Inc.

Federman & Sherwood Announces Filing Of Securities Class Action Lawsuit Against TG Therapeutics, Inc.

Federman & Sherwood Announces Filing Of Securities Class Action Lawsuit Against TG Therapeutics, Inc.

Federman & Sherwood announces that on October 4, 2018, a class action lawsuit was filed in the United States District Court for the Southern District of New York against TG Therapeutics, Inc.

Scott Scott Attorneys At Law LLP Alerts Investors To Securities Class Action Against TG Therapeutics, Inc. (TGTX)

Scott Scott Attorneys At Law LLP Alerts Investors To Securities Class Action Against TG Therapeutics, Inc. (TGTX)

NEW YORK, Oct. 10, 2018 /PRNewswire/ --  Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, is notifying investors that a class action lawsuit has been filed against TG Therapeutics, Inc.

INVESTOR ALERT: Ademi & O'Reilly, LLP Reminds Investors In TG Therapeutics, Inc. (TGTX) Of December 3 Deadline

INVESTOR ALERT: Ademi & O'Reilly, LLP Reminds Investors In TG Therapeutics, Inc. (TGTX) Of December 3 Deadline

MILWAUKEE, Oct. 8, 2018 /PRNewswire/ -- Ademi & O'Reilly, LLP announces that a class action lawsuit has been filed against TG Therapeutics, Inc.

TG THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In TG Therapeutics, Inc. To Contact The Firm

TG THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In TG Therapeutics, Inc. To Contact The Firm

NEW YORK, Oct. 5, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against TG Therapeutics, Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against TG Therapeutics, Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against TG Therapeutics, Inc.

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of TG Therapeutics, Inc.

Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against TG Therapeutics, Inc.

Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against TG Therapeutics, Inc.

Robbins Geller Rudman & Dowd LLP ( http://www.rgrdlaw.

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors Of Class Action Against TG Therapeutics, Inc. (TGTX)

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors Of Class Action Against TG Therapeutics, Inc. (TGTX)

NEW YORK, Oct. 4, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against TG Therapeutics, Inc.

Noteworthy Friday Option Activity: TGTX, CIVB, RST

Noteworthy Friday Option Activity: TGTX, CIVB, RST

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in TG Therapeutics Inc , where a total of 29,923 contracts have traded so far, representing approximately 3.0 million underlying shares. That amounts to about 252.7% of TGTX's average daily trading volume over the past month of 1.2 million shares.

First Week Of January 2021 Options Trading For TG Therapeutics (TGTX)

First Week Of January 2021 Options Trading For TG Therapeutics (TGTX)

Investors in TG Therapeutics Inc saw new options become available this week, for the January 2021 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 850 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

TheStreet Quant Rating: D- (Sell)